364 related articles for article (PubMed ID: 31097457)
1. Recreational and ergogenic substance use and substance use disorders in elite athletes: a narrative review.
McDuff D; Stull T; Castaldelli-Maia JM; Hitchcock ME; Hainline B; Reardon CL
Br J Sports Med; 2019 Jun; 53(12):754-760. PubMed ID: 31097457
[TBL] [Abstract][Full Text] [Related]
2. Use of psychotropic substances among elite athletes - a narrative review.
Exner J; Bitar R; Berg X; Pichler EM; Herdener M; Seifritz E; Claussen MC
Swiss Med Wkly; 2021 Feb; 151():w20412. PubMed ID: 33638352
[TBL] [Abstract][Full Text] [Related]
3. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
Negro F; Di Trana A; Marinelli S
Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
[TBL] [Abstract][Full Text] [Related]
4. The sports psychiatrist and performance-enhancing drugs.
Creado S; Reardon C
Int Rev Psychiatry; 2016 Dec; 28(6):564-571. PubMed ID: 27310472
[TBL] [Abstract][Full Text] [Related]
5. Australian athletes' knowledge of the WADA Prohibited Substances List and performance enhancing substances.
Orr R; Grassmayr M; Macniven R; Grunseit A; Halaki M; Bauman A
Int J Drug Policy; 2018 Jun; 56():40-45. PubMed ID: 29550541
[TBL] [Abstract][Full Text] [Related]
6. Is there a danger for myopia in anti-doping education? Comparative analysis of substance use and misuse in Olympic racket sports calls for a broader approach.
Kondric M; Sekulic D; Petroczi A; Ostojic L; Rodek J; Ostojic Z
Subst Abuse Treat Prev Policy; 2011 Oct; 6():27. PubMed ID: 21988896
[TBL] [Abstract][Full Text] [Related]
7. Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study.
Piacentino D; Kotzalidis GD; Longo L; Pavan A; Stivali L; Stivali G; Ferracuti S; Brugnoli R; Frati P; Fineschi V; Girardi P; Sani G
J Psychoactive Drugs; 2017; 49(5):373-384. PubMed ID: 28777732
[TBL] [Abstract][Full Text] [Related]
8. Nicotine: Sporting Friend or Foe? A Review of Athlete Use, Performance Consequences and Other Considerations.
Mündel T
Sports Med; 2017 Dec; 47(12):2497-2506. PubMed ID: 28791650
[TBL] [Abstract][Full Text] [Related]
9. Success, Failure, and Unfinished Business of Education, Prevention, Policy, and Intervention Programs on Substance Misuse in Brazilian Sport.
Santos AM
Subst Use Misuse; 2015; 50(8-9):1139-43. PubMed ID: 26361918
[TBL] [Abstract][Full Text] [Related]
10. [Young elite athletes: which health risk they are taking?].
Weimann E
MMW Fortschr Med; 2014 Jul; 156(13):37-9. PubMed ID: 25318222
[No Abstract] [Full Text] [Related]
11. Cannabis and the Health and Performance of the Elite Athlete.
Ware MA; Jensen D; Barrette A; Vernec A; Derman W
Clin J Sport Med; 2018 Sep; 28(5):480-484. PubMed ID: 30153174
[TBL] [Abstract][Full Text] [Related]
12. Performance-enhancing substances in sports: a review of the literature.
Momaya A; Fawal M; Estes R
Sports Med; 2015 Apr; 45(4):517-31. PubMed ID: 25663250
[TBL] [Abstract][Full Text] [Related]
13. Predicting attitude towards performance enhancing substance use: a comprehensive test of the Sport Drug Control Model with elite Australian athletes.
Jalleh G; Donovan RJ; Jobling I
J Sci Med Sport; 2014 Nov; 17(6):574-9. PubMed ID: 24268440
[TBL] [Abstract][Full Text] [Related]
14. Treating the elite athlete: anti-doping information for the health professional.
Tandon S; Bowers LD; Fedoruk MN
Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge.
Gild ML; Stuart M; Clifton-Bligh RJ; Kinahan A; Handelsman DJ
J Clin Endocrinol Metab; 2022 Aug; 107(9):e3562-e3573. PubMed ID: 35438767
[TBL] [Abstract][Full Text] [Related]
16. Effects of caffeine supplementation on physical performance and mood dimensions in elite and trained-recreational athletes.
Jodra P; Lago-Rodríguez A; Sánchez-Oliver AJ; López-Samanes A; Pérez-López A; Veiga-Herreros P; San Juan AF; Domínguez R
J Int Soc Sports Nutr; 2020 Jan; 17(1):2. PubMed ID: 31900166
[TBL] [Abstract][Full Text] [Related]
17. Self-reported attitudes of elite athletes towards doping: differences between type of sport.
Alaranta A; Alaranta H; Holmila J; Palmu P; Pietilä K; Helenius I
Int J Sports Med; 2006 Oct; 27(10):842-6. PubMed ID: 16586338
[TBL] [Abstract][Full Text] [Related]
18. Substance Misuse in Elite Athletes: Early Detection, Brief Intervention and Referral to Treatment.
McDuff DR; Garvin M; Joy Chang ; Thompson D
Clin Sports Med; 2024 Jan; 43(1):127-144. PubMed ID: 37949506
[TBL] [Abstract][Full Text] [Related]
19. Risk profile of male college athletes who use performance-enhancing substances.
Buckman JF; Yusko DA; White HR; Pandina RJ
J Stud Alcohol Drugs; 2009 Nov; 70(6):919-23. PubMed ID: 19895768
[TBL] [Abstract][Full Text] [Related]
20. An (un)desirable trade of harms? How elite athletes might react to medically supervised 'doping' and their considerations of side-effects in this situation.
Overbye M
Int J Drug Policy; 2018 May; 55():14-30. PubMed ID: 29477956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
